Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

It's a SMAD/SMAD World.

Cullen Taniguchi1, Anirban Maitra2

  • 1Departments of Radiation Oncology, Experimental Radiation Oncology, and Cancer Biology, UT MD Anderson Cancer Center, Houston, TX, 77030, USA.

Cell
|June 6, 2015
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis.

Science (New York, N.Y.)·2021
Same author

GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2021
Same author

Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies.

Clinical cancer research : an official journal of the American Association for Cancer Research·2021
Same author

Early detection of pancreatic cancer: current state and future opportunities.

Current opinion in gastroenterology·2021
Same author

PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma.

Nature communications·2021
Same author

Longitudinal assessment of lung clearance index to monitor disease progression in children and adults with cystic fibrosis.

Thorax·2021
Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
See all related articles

Runx3 expression and DPC4/SMAD4 gene status can predict pancreatic cancer metastasis. This finding offers guidance for personalized pancreatic cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • DPC4/SMAD4 mutations are linked to aggressive pancreatic ductal adenocarcinoma.
  • Understanding the molecular drivers of pancreatic cancer metastasis is crucial for effective treatment.

Purpose of the Study:

  • To investigate the role of Runx3 expression in conjunction with DPC4/SMAD4 status.
  • To determine if this combination can predict the metastatic potential of pancreatic tumors.

Main Methods:

  • Analysis of Runx3 expression levels in pancreatic tumor samples.
  • Correlation of Runx3 expression and DPC4/SMAD4 mutation status with metastatic outcomes.

Main Results:

  • Runx3 expression, when evaluated alongside DPC4/SMAD4 status, effectively predicts the metastatic propensity of pancreatic tumors.

Related Experiment Videos

  • This combined biomarker approach offers a novel method for assessing tumor aggressiveness.

    • Conclusions:

    • The combined assessment of Runx3 expression and DPC4/SMAD4 status provides valuable prognostic information for pancreatic cancer patients.
    • This predictive model can guide the development of personalized therapeutic strategies for pancreatic cancer.